FMC - Bolivar is a medicare approved dialysis facility center in Bolivar, Missouri and it has 12 dialysis stations. It is located in Polk county at 2101 W Broadway, Bolivar, MO, 65613. You can reach out to the office of FMC - Bolivar at (417) 326-3112. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC - Bolivar has the following ownership type - Profit. It was first certified by medicare in March, 1998. The medicare id for this facility is 262559 and it accepts patients under medicare ESRD program.
| Name | FMC - Bolivar |
|---|---|
| Location | 2101 W Broadway, Bolivar, Missouri |
| No. of Dialysis Stations | 12 |
| Medicare ID | 262559 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 2101 W Broadway, Bolivar, Missouri, 65613 | |
| (417) 326-3112 | |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has received approval for the treatment of Macular Edema Following Central Retinal Vein Occlusion from the Japanese Ministry of Health, Labour and Welfare.
Researchers at the University of Maryland, Baltimore County have developed do-it-yourself assistive technology prototypes that are revolutionizing how people with disabilities can access tools that will help them interact with the world.
Johns Hopkins scientists have been awarded a $3.7 million grant from the National Institutes of Health (NIH) to learn more about the nerve and muscle-wasting disease amyotrophic lateral sclerosis (ALS) using stem cells developed from ALS patients' skin. The award, given over a two-year span, will be shared with three other laboratories, including one at Harvard University and two at Columbia University.
Lovers of Indian food, give yourselves a second helping: Daily consumption of a certain form of curcumin - the substance that gives Indian curry its bright color - improved memory and mood in people with mild, age-related memory loss, according to the results of a study conducted by UCLA researchers.
› Verified 4 days ago
| NPI Number | 1396857264 |
| Organization Name | Renal Care Group Bolivar |
| Doing Business As | Renal Care Group Of The Ozarks, Llc |
| Address | 1145 N Butterfield Rd Bolivar, Missouri, 65613 |
| Phone Number | (417) 777-8115 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has received approval for the treatment of Macular Edema Following Central Retinal Vein Occlusion from the Japanese Ministry of Health, Labour and Welfare.
Researchers at the University of Maryland, Baltimore County have developed do-it-yourself assistive technology prototypes that are revolutionizing how people with disabilities can access tools that will help them interact with the world.
Johns Hopkins scientists have been awarded a $3.7 million grant from the National Institutes of Health (NIH) to learn more about the nerve and muscle-wasting disease amyotrophic lateral sclerosis (ALS) using stem cells developed from ALS patients' skin. The award, given over a two-year span, will be shared with three other laboratories, including one at Harvard University and two at Columbia University.
Lovers of Indian food, give yourselves a second helping: Daily consumption of a certain form of curcumin - the substance that gives Indian curry its bright color - improved memory and mood in people with mild, age-related memory loss, according to the results of a study conducted by UCLA researchers.
› Verified 4 days ago
| Dialysis patients with Hemoglobin data | 34 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 24 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has received approval for the treatment of Macular Edema Following Central Retinal Vein Occlusion from the Japanese Ministry of Health, Labour and Welfare.
Researchers at the University of Maryland, Baltimore County have developed do-it-yourself assistive technology prototypes that are revolutionizing how people with disabilities can access tools that will help them interact with the world.
Johns Hopkins scientists have been awarded a $3.7 million grant from the National Institutes of Health (NIH) to learn more about the nerve and muscle-wasting disease amyotrophic lateral sclerosis (ALS) using stem cells developed from ALS patients' skin. The award, given over a two-year span, will be shared with three other laboratories, including one at Harvard University and two at Columbia University.
Lovers of Indian food, give yourselves a second helping: Daily consumption of a certain form of curcumin - the substance that gives Indian curry its bright color - improved memory and mood in people with mild, age-related memory loss, according to the results of a study conducted by UCLA researchers.
› Verified 4 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 61 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 475 |
| Percentage of adult patients getting regular hemodialysis at the center | 96 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has received approval for the treatment of Macular Edema Following Central Retinal Vein Occlusion from the Japanese Ministry of Health, Labour and Welfare.
Researchers at the University of Maryland, Baltimore County have developed do-it-yourself assistive technology prototypes that are revolutionizing how people with disabilities can access tools that will help them interact with the world.
Johns Hopkins scientists have been awarded a $3.7 million grant from the National Institutes of Health (NIH) to learn more about the nerve and muscle-wasting disease amyotrophic lateral sclerosis (ALS) using stem cells developed from ALS patients' skin. The award, given over a two-year span, will be shared with three other laboratories, including one at Harvard University and two at Columbia University.
Lovers of Indian food, give yourselves a second helping: Daily consumption of a certain form of curcumin - the substance that gives Indian curry its bright color - improved memory and mood in people with mild, age-related memory loss, according to the results of a study conducted by UCLA researchers.
› Verified 4 days ago
| Adult patients getting regular peritoneal dialysis at the center | 38 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 306 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 98 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has received approval for the treatment of Macular Edema Following Central Retinal Vein Occlusion from the Japanese Ministry of Health, Labour and Welfare.
Researchers at the University of Maryland, Baltimore County have developed do-it-yourself assistive technology prototypes that are revolutionizing how people with disabilities can access tools that will help them interact with the world.
Johns Hopkins scientists have been awarded a $3.7 million grant from the National Institutes of Health (NIH) to learn more about the nerve and muscle-wasting disease amyotrophic lateral sclerosis (ALS) using stem cells developed from ALS patients' skin. The award, given over a two-year span, will be shared with three other laboratories, including one at Harvard University and two at Columbia University.
Lovers of Indian food, give yourselves a second helping: Daily consumption of a certain form of curcumin - the substance that gives Indian curry its bright color - improved memory and mood in people with mild, age-related memory loss, according to the results of a study conducted by UCLA researchers.
› Verified 4 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC - Bolivar with elevated calcium levels.
| Patients with hypercalcemia | 97 |
| Hypercalcemia patient months | 846 |
| Patients with Serumphosphor | 99 |
| Patients with Serumphosphor less than 3.5 mg/dL | 8 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 29 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 29 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 25 |
| Patients with Serumphosphor greater than 7 mg/dL | 10 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has received approval for the treatment of Macular Edema Following Central Retinal Vein Occlusion from the Japanese Ministry of Health, Labour and Welfare.
Researchers at the University of Maryland, Baltimore County have developed do-it-yourself assistive technology prototypes that are revolutionizing how people with disabilities can access tools that will help them interact with the world.
Johns Hopkins scientists have been awarded a $3.7 million grant from the National Institutes of Health (NIH) to learn more about the nerve and muscle-wasting disease amyotrophic lateral sclerosis (ALS) using stem cells developed from ALS patients' skin. The award, given over a two-year span, will be shared with three other laboratories, including one at Harvard University and two at Columbia University.
Lovers of Indian food, give yourselves a second helping: Daily consumption of a certain form of curcumin - the substance that gives Indian curry its bright color - improved memory and mood in people with mild, age-related memory loss, according to the results of a study conducted by UCLA researchers.
› Verified 4 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 55 |
| Patient months included in arterial venous fistula and catheter summaries | 380 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 54 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 17 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has received approval for the treatment of Macular Edema Following Central Retinal Vein Occlusion from the Japanese Ministry of Health, Labour and Welfare.
Researchers at the University of Maryland, Baltimore County have developed do-it-yourself assistive technology prototypes that are revolutionizing how people with disabilities can access tools that will help them interact with the world.
Johns Hopkins scientists have been awarded a $3.7 million grant from the National Institutes of Health (NIH) to learn more about the nerve and muscle-wasting disease amyotrophic lateral sclerosis (ALS) using stem cells developed from ALS patients' skin. The award, given over a two-year span, will be shared with three other laboratories, including one at Harvard University and two at Columbia University.
Lovers of Indian food, give yourselves a second helping: Daily consumption of a certain form of curcumin - the substance that gives Indian curry its bright color - improved memory and mood in people with mild, age-related memory loss, according to the results of a study conducted by UCLA researchers.
› Verified 4 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 77 |
| Hospitalization Rate in facility | 160.3 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 280.9 |
| Hospitalization Rate: Lower Confidence Limit | 94.3 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has received approval for the treatment of Macular Edema Following Central Retinal Vein Occlusion from the Japanese Ministry of Health, Labour and Welfare.
Researchers at the University of Maryland, Baltimore County have developed do-it-yourself assistive technology prototypes that are revolutionizing how people with disabilities can access tools that will help them interact with the world.
Johns Hopkins scientists have been awarded a $3.7 million grant from the National Institutes of Health (NIH) to learn more about the nerve and muscle-wasting disease amyotrophic lateral sclerosis (ALS) using stem cells developed from ALS patients' skin. The award, given over a two-year span, will be shared with three other laboratories, including one at Harvard University and two at Columbia University.
Lovers of Indian food, give yourselves a second helping: Daily consumption of a certain form of curcumin - the substance that gives Indian curry its bright color - improved memory and mood in people with mild, age-related memory loss, according to the results of a study conducted by UCLA researchers.
› Verified 4 days ago
The rate of readmission show you whether patients who were being treated regularly at FMC - Bolivar were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 26.4 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 40.3 |
| Readmission Rate: Lower Confidence Limit | 15.4 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has received approval for the treatment of Macular Edema Following Central Retinal Vein Occlusion from the Japanese Ministry of Health, Labour and Welfare.
Researchers at the University of Maryland, Baltimore County have developed do-it-yourself assistive technology prototypes that are revolutionizing how people with disabilities can access tools that will help them interact with the world.
Johns Hopkins scientists have been awarded a $3.7 million grant from the National Institutes of Health (NIH) to learn more about the nerve and muscle-wasting disease amyotrophic lateral sclerosis (ALS) using stem cells developed from ALS patients' skin. The award, given over a two-year span, will be shared with three other laboratories, including one at Harvard University and two at Columbia University.
Lovers of Indian food, give yourselves a second helping: Daily consumption of a certain form of curcumin - the substance that gives Indian curry its bright color - improved memory and mood in people with mild, age-related memory loss, according to the results of a study conducted by UCLA researchers.
› Verified 4 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at FMC - Bolivar get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .94 (As Expected) |
| SIR: Upper Confidence Limit | 2.27 |
| SIR: Lower Confidence Limit | .3 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has received approval for the treatment of Macular Edema Following Central Retinal Vein Occlusion from the Japanese Ministry of Health, Labour and Welfare.
Researchers at the University of Maryland, Baltimore County have developed do-it-yourself assistive technology prototypes that are revolutionizing how people with disabilities can access tools that will help them interact with the world.
Johns Hopkins scientists have been awarded a $3.7 million grant from the National Institutes of Health (NIH) to learn more about the nerve and muscle-wasting disease amyotrophic lateral sclerosis (ALS) using stem cells developed from ALS patients' skin. The award, given over a two-year span, will be shared with three other laboratories, including one at Harvard University and two at Columbia University.
Lovers of Indian food, give yourselves a second helping: Daily consumption of a certain form of curcumin - the substance that gives Indian curry its bright color - improved memory and mood in people with mild, age-related memory loss, according to the results of a study conducted by UCLA researchers.
› Verified 4 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether FMC - Bolivar's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 66 |
| Transfusion Rate in facility | 16.3 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 69.1 |
| Transfusion Rate: Lower Confidence Limit | 4.6 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has received approval for the treatment of Macular Edema Following Central Retinal Vein Occlusion from the Japanese Ministry of Health, Labour and Welfare.
Researchers at the University of Maryland, Baltimore County have developed do-it-yourself assistive technology prototypes that are revolutionizing how people with disabilities can access tools that will help them interact with the world.
Johns Hopkins scientists have been awarded a $3.7 million grant from the National Institutes of Health (NIH) to learn more about the nerve and muscle-wasting disease amyotrophic lateral sclerosis (ALS) using stem cells developed from ALS patients' skin. The award, given over a two-year span, will be shared with three other laboratories, including one at Harvard University and two at Columbia University.
Lovers of Indian food, give yourselves a second helping: Daily consumption of a certain form of curcumin - the substance that gives Indian curry its bright color - improved memory and mood in people with mild, age-related memory loss, according to the results of a study conducted by UCLA researchers.
› Verified 4 days ago
The rate of mortality show you whether patients who were being treated regularly at FMC - Bolivar lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 345 |
| Mortality Rate in facility | 19.6 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 25.3 |
| Mortality Rate: Lower Confidence Limit | 14.9 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has received approval for the treatment of Macular Edema Following Central Retinal Vein Occlusion from the Japanese Ministry of Health, Labour and Welfare.
Researchers at the University of Maryland, Baltimore County have developed do-it-yourself assistive technology prototypes that are revolutionizing how people with disabilities can access tools that will help them interact with the world.
Johns Hopkins scientists have been awarded a $3.7 million grant from the National Institutes of Health (NIH) to learn more about the nerve and muscle-wasting disease amyotrophic lateral sclerosis (ALS) using stem cells developed from ALS patients' skin. The award, given over a two-year span, will be shared with three other laboratories, including one at Harvard University and two at Columbia University.
Lovers of Indian food, give yourselves a second helping: Daily consumption of a certain form of curcumin - the substance that gives Indian curry its bright color - improved memory and mood in people with mild, age-related memory loss, according to the results of a study conducted by UCLA researchers.
› Verified 4 days ago
News Archive
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has received approval for the treatment of Macular Edema Following Central Retinal Vein Occlusion from the Japanese Ministry of Health, Labour and Welfare.
Researchers at the University of Maryland, Baltimore County have developed do-it-yourself assistive technology prototypes that are revolutionizing how people with disabilities can access tools that will help them interact with the world.
Johns Hopkins scientists have been awarded a $3.7 million grant from the National Institutes of Health (NIH) to learn more about the nerve and muscle-wasting disease amyotrophic lateral sclerosis (ALS) using stem cells developed from ALS patients' skin. The award, given over a two-year span, will be shared with three other laboratories, including one at Harvard University and two at Columbia University.
Lovers of Indian food, give yourselves a second helping: Daily consumption of a certain form of curcumin - the substance that gives Indian curry its bright color - improved memory and mood in people with mild, age-related memory loss, according to the results of a study conducted by UCLA researchers.
› Verified 4 days ago